Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Australia's Insignia Financial says Bain Capital pulls buyout bid, in talks with CC Capital
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Waystar Holding (WAY) proposed public offering of 12.5 million shares
-
Waystar Announces Proposed Public Offering of Common Stock
-
Rocket Software Unveils Innovations to Scale IT Impact Through Resilience, Automation, and AI-Powered Agility
-
Argyle debuts integration with Encompass Consumer Connect, upgrades existing integration with Encompass from ICE Mortgage Technology
-
Origin Specialty Underwriters Launches New Specialty Property Program Backed by Emerald Bay
-
ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ICIC’s 2025 Innovation Summit: Ingenuity, Community, and Growth
-
Redwire Corporation Reports First Quarter 2025 Financial Results
-
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Bain Capital to sell China data centre business likely valued at over $4 billion, sources say
-
Bain Capital and Oliver Street Capital Acquire 11-Property Infill Industrial Portfolio in Northern New Jersey
-
BermudAir Partners with Zero Hash to Launch First-of-Its-Kind Stablecoin Payments in Air Travel
-
Argyle integrates with Tidalwave to deliver embedded, real-time verification of income and employment
-
Lincoln Financial Reports 2025 First Quarter Results
-
Cadent chooses OverIT's FSM platform to modernise its Field Operations for 3,600 users across the UK
-
US school districts facing extortion attempt after hack, software provider says
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Tanjong Malim Land Investment Opportunities: New Guide By Sungai Samak Estate
-
Alkeus Pharmaceuticals Presents Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
-
Bain Capital and Botanic Properties Acquire Greater Boston Property for Biomanufacturing Conversion
-
Koala Health Secures Series B Funding to Revolutionize Chronic Pet Medication Delivery
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics
-
Form 8-K Bain Capital Specialty For: May 05
-
Bain Capital Specialty Finance, Inc. Announces March 31, 2025 Financial Results and Declares Second Quarter 2025 Dividend of $0.42 per Share
-
Form SCHEDULE 13D/A Bain Capital Private Filed by: Bain Capital DCB Investments, LP
-
Form 10-Q Bain Capital Specialty For: Mar 31
-
Qwiet AI Honored as Winner of the 2025 SC Awards
-
GraniteShares ETFs Announces Change to the Investment Objective on one of its Inverse Leveraged ETFs
-
Ares Management Announces First Quarter 2025 U.S. Direct Lending Origination Activity
-
ROSEN, A Top Ranked Law Firm, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, A Leading Law Firm, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Form 8-K Bain Capital Specialty For: Apr 28
-
Valeo Foods Group Acquires Freddi Dolciaria S.p.A, Enhancing its Position in the Italian Bakery Sector
-
Form SC TO-I Bain Capital Private Filed by: Bain Capital Private Credit
-
Form SC TO-I/A Bain Capital Private Filed by: Bain Capital Private Credit
-
Casago Completes Acquisition of Vacasa
-
Astronomer Secures $93 Million Series D Funding to Deliver Unified DataOps Platform for Enterprise AI
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
Form 8-K Bain Capital Specialty For: Apr 28
-
Form 8-K Bain Capital Private For: Apr 28
-
Form 486BPOS Bain Capital Private
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Vinarchy: A New Global Wine Company
